Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Statement of Cash Flows [Abstract]
Net loss	$ (10,029,591)	$ (4,146,796)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	47,916	109,413
Share-based compensation	836,866	164,810
Fair value of common stock issued for charitable contribution		113,400
Fair value of common stock and warrants issued for services	448,940	935,144
Fair value of options issued for services		59,471
Derivative warrant liability (gain) loss	1,762,938	(371,345)
Non-cash (gain) loss on extinguishment of debt	1,514	(183,863)
Non-cash interest expense	12,159	35,190
Non-cash loss on disposal of assets	5,688
Changes in assets and liabilities:
Accounts receivable	104,423	(11,452)
Prepaid expenses and other current assets	(79,003)	31,436
Deposits and other assets	(576)	1,750
Accounts payable	(240,336)	(320,078)
Deferred revenue	(302,059)	(225,868)
Accrued expenses and other liabilities	505,184	178,969
Net cash used in operating activities	(6,925,937)	(3,629,819)
Cash Flows from Investing Activities:
Purchase of property and equipment	(323,301)	(14,415)
Decrease (increase) in restricted cash	5,510	(265,500)
Net cash used in investing activities	(317,791)	(279,915)
Cash Flows From Financing Activities:
Proceeds from the exercise of warrants	4,919,346
Proceeds from issuance of common stock and warrants, net of issuance costs	6,439,489	3,886,794
Principal payments for capital lease obligations	(2,071)	(1,874)
Proceeds from issuance of Series D Convertible Preferred Stock and warrants, net of issuance costs	2,478,701
Proceeds from bridge notes	1,000,000	250,000
Repayment of bridge notes	(75,000)	(50,000)
Proceeds from exercise of stock options, net of forfeitures	136,790
Net cash provided by financing activities	14,897,255	4,084,920
Net increase in cash and cash equivalents	7,653,527	175,186
Cash and cash equivalents, beginning of period	1,342,044	1,166,858
Cash and cash equivalents, end of period	8,995,571	1,342,044
Supplemental Disclosure of Cash Flow Information and Non Cash Financing Transactions:
Cash paid for interest	1,768	2,124
Accretion of dividend on Series B Perpetual Redeemable Preferred Stock	157,733	131,659
Issuance of common stock in settlement of short term note	35,500	100,000
Issuance of common stock in settlement of accounts payable		23,000
Issuance of common stock in connection with issuance of promissory notes		48,500
Conversion of notes payable and accrued interest into Series D Convertible Preferred Stock	1,006,000
Conversion of Series D Convertible Preferred Stock into Common Stock	500,000
Deemed dividend on beneficial conversion of Series D Convertible Preferred Stock	1,975,211
Redemption of Series B Perpetual Redeemable Preferred Stock for Series C Preferred Stock in connection with October 27, 2011 warrant exercises	1,701,672
Reclassification of derivative warrant liability to additional paid-in capital	2,272,597	200,357
Fair value of warrants included in stock issuance costs	41,363	468,741
Common stock subscription receivable	6,667	285,000
Cancellation of restricted Common Stock	5,250
Deemed dividend on repricing of warrants	4,559,761
Fair value of restricted stock issued in connection with settlement agreement	$ 290,000